Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells

Cancer Letters

Volumn 329, Issue 2, 2013, Pages 197-206

  Cheng, Jung Chien ^a   Klausen, Christian ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

E cadherin; EGF; HIF 1 ; Ovarian cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; UPREGULATION;

CADHERINS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; COBALT; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS;

GASTROPODA;

EID: 84872494457     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.10.029     Document Type: Article

References (58)

1. 2 tension. Proc. Natl. Acad. Sci. USA 1995, 92:5510-5514.
2. Feldser D., Agani F., Iyer N.V., Pak B., Ferreira G., Semenza G.L. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 1999, 59:3915-3918.
3. Richard D.E., Berra E., Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 2000, 275:26765-26771.
4. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., Simons J.W., Semenza G.L. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 2000, 60:1541-1545.
5. Harris A.L. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002, 2:38-47.
6. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999, 59:5830-5835.
7. Talks K.L., Turley H., Gatter K.C., Maxwell P.H., Pugh C.W., Ratcliffe P.J., Harris A.L. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 2000, 157:411-421.
8. Birner P., Schindl M., Obermair A., Breitenecker G., Oberhuber G. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin. Cancer Res. 2001, 7:1661-1668.
9. Wong C., Wellman T.L., Lounsbury K.M. VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer. Gynecol. Oncol. 2003, 91:513-517.
10. Daponte A., Ioannou M., Mylonis I., Simos G., Minas M., Messinis I.E., Koukoulis G. Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1 alpha) expression in serous ovarian cancer: an immunohistochemical study. BMC Cancer 2008, 8:335.
11. Nakai H., Watanabe Y., Ueda H., Hoshiai H. Hypoxia inducible factor 1-alpha expression as a factor predictive of efficacy of taxane/platinum chemotherapy in advanced primary epithelial ovarian cancer. Cancer Lett. 2007, 251:164-167.
12. Osada R., Horiuchi A., Kikuchi N., Yoshida J., Hayashi A., Ota M., Katsuyama Y., Melillo G., Konishi I. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Hum. Pathol. 2007, 38:1310-1320.
13. Seeber L.M., Horree N., Vooijs M.A., Heintz A.P., van der Wall E., Verheijen R.H., van Diest P.J. The role of hypoxia inducible factor-1alpha in gynecological cancer. Crit. Rev. Oncol. Hematol. 2011, 78:173-184.
14. Birchmeier W., Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1994, 1198:11-26.
15. Voulgari A., Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim. Biophys. Acta 2009, 1796:75-90.
16. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009, 28:151-166.
17. Dian D., Bruning A., Mylonas I. E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis. Arch. Gynecol. Obstet. 2011, 284:437-443.
18. Quattrocchi L., Green A.R., Martin S., Durrant L., Deen S. The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression. Virchows Arch. 2011, 459:21-29.
19. Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Lochner D., Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 1991, 113:173-185.
20. Cheng J.C., Klausen C., Leung P.C. Hydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells. Mol. Endocrinol. 2010, 24:1569-1580.
21. Yuecheng Y., Hongmei L., Xiaoyan X. Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer. Clin. Exp. Metastasis 2006, 23:65-74.
22. Imai T., Horiuchi A., Wang C., Oka K., Ohira S., Nikaido T., Konishi I. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am. J. Pathol. 2003, 163:1437-1447.
23. El-Rayes B.F., LoRusso P.M. Targeting the epidermal growth factor receptor. Br. J. Cancer 2004, 91:418-424.
24. Marmor M.D., Skaria K.B., Yarden Y. Signal transduction and oncogenesis by ErbB/HER receptors. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:903-913.
25. Barr S., Thomson S., Buck E., Russo S., Petti F., Sujka-Kwok I., Eyzaguirre A., Rosenfeld-Franklin M., Gibson N.W., Miglarese M., Epstein D., Iwata K.K., Haley J.D. Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clin. Exp. Metastasis 2008, 25:685-693.
26. Bartlett J.M., Langdon S.P., Simpson B.J., Stewart M., Katsaros D., Sismondi P., Love S., Scott W.N., Williams A.R., Lessells A.M., Macleod K.G., Smyth J.F., Miller W.R. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br. J. Cancer 1996, 73:301-306.
27. Niikura H., Sasano H., Sato S., Yajima A. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors. Int. J. Gynecol. Pathol. 1997, 16:60-68.
28. Mendelsohn J., Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J. Clin. Oncol. 2003, 21:2787-2799.
29. Liu L.Z., Hu X.W., Xia C., He J., Zhou Q., Shi X., Fang J., Jiang B.H. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic. Biol. Med. 2006, 41:1521-1533.
30. Woo M.M., Salamanca C.M., Minor A., Auersperg N. An improved assay to quantitate the invasiveness of cells in modified Boyden chambers. In Vitro Cell. Dev. Biol. Anim. 2007, 43:7-9.
31. Cheng J.C., Chang H.M., Leung P.C. Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells. Oncogene 2012.
32. Bae S., Jeong H.J., Cha H.J., Kim K., Choi Y.M., An I.S., Koh H.J., Lim D.J., Lee S.J., An S. The hypoxia-mimetic agent cobalt chloride induces cell cycle arrest and alters gene expression in U266 multiple myeloma cells. Int. J. Mol. Med. 2012, 30:1180-1186.
33. Bensellam M., Duvillie B., Rybachuk G., Laybutt D.R., Magnan C., Guiot Y., Pouyssegur J., Jonas J.C. Glucose-induced O(2) consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells. PLoS ONE 2012, 7:e29807.
34. Busch W., Kuhnel D., Schirmer K., Scholz S. Tungsten carbide cobalt nanoparticles exert hypoxia-like effects on the gene expression level in human keratinocytes. BMC Genomics 2010, 11:65.
35. Maxwell P., Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol. Ther. 2004, 3:29-35.
36. Cowden Dahl K.D., Symowicz J., Ning Y., Gutierrez E., Fishman D.A., Adley B.P., Stack M.S., Hudson L.G. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res. 2008, 68:4606-4613.
37. Lu Z., Ghosh S., Wang Z., Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003, 4:499-515.
38. Bast R.C., Hennessy B., Mills G.B. The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer 2009, 9:415-428.
39. Kobel M., Kalloger S.E., Boyd N., McKinney S., Mehl E., Palmer C., Leung S., Bowen N.J., Ionescu D.N., Rajput A., Prentice L.M., Miller D., Santos J., Swenerton K., Gilks C.B., Huntsman D. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2008, 5:e232.
40. Miyazawa M., Yasuda M., Fujita M., Hirasawa T., Kajiwara H., Hirabayashi K., Ogane N., Shimizu M., Asanuma H., Murakami M., Takekoshi S., Mikami M., Osamura R.Y. Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1. Arch. Gynecol. Obstet. 2009, 279:789-796.
41. Anglesio M.S., George J., Kulbe H., Friedlander M., Rischin D., Lemech C., Power J., Coward J., Cowin P.A., House C.M., Chakravarty P., Gorringe K.L., Campbell I.G., Okamoto A., Birrer M.J., Huntsman D.G., de Fazio A., Kalloger S.E., Balkwill F., Gilks C.B., Bowtell D.D. IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clin. Cancer Res. 2011, 17:2538-2548.
42. Stany M.P., Vathipadiekal V., Ozbun L., Stone R.L., Mok S.C., Xue H., Kagami T., Wang Y., McAlpine J.N., Bowtell D., Gout P.W., Miller D.M., Gilks C.B., Huntsman D.G., Ellard S.L., Wang Y.Z., Vivas-Mejia P., Lopez-Berestein G., Sood A.K., Birrer M.J. Identification of novel therapeutic targets in microdissected clear cell ovarian cancers. PLoS ONE 2011, 6:e21121.
43. Yamaguchi K., Mandai M., Oura T., Matsumura N., Hamanishi J., Baba T., Matsui S., Murphy S.K., Konishi I. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Oncogene 2010, 29:1741-1752.
44. Shaw T.J., Senterman M.K., Dawson K., Crane C.A., Vanderhyden B.C. Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Mol. Ther. 2004, 10:1032-1042.
45. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
46. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M., Semenza G.L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 2002, 277:38205-38211.
47. Zhou Q., Liu L.Z., Fu B., Hu X., Shi X., Fang J., Jiang B.H. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis 2007, 28:28-37.
48. Gao N., Nester R.A., Sarkar M.A. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Toxicol. Appl. Pharmacol. 2004, 196:124-135.
49. Hua K., Din J., Cao Q., Feng W., Zhang Y., Yao L., Huang Y., Zhao Y., Feng Y. Estrogen and progestin regulate HIF-1alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. Oncol. Rep. 2009, 21:893-898.
50. Huang Y., Hua K., Zhou X., Jin H., Chen X., Lu X., Yu Y., Zha X., Feng Y. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma. Cell Res. 2008, 18:780-791.
51. Song G., Cai Q.F., Mao Y.B., Ming Y.L., Bao S.D., Ouyang G.L. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway. Cancer Sci. 2008, 99:1901-1907.
52. Veatch A.L., Carson L.F., Ramakrishnan S. Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int. J. Cancer 1994, 58:393-399.
53. Darai E., Scoazec J.Y., Walker-Combrouze F., Mlika-Cabanne N., Feldmann G., Madelenat P., Potet F. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. Hum. Pathol. 1997, 28:922-928.
54. Elloul S., Silins I., Trope C.G., Benshushan A., Davidson B., Reich R. Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch. 2006, 449:520-528.
55. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
56. Jiao W., Miyazaki K., Kitajima Y. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br. J. Cancer 2002, 86:98-101.
57. Poser I., Dominguez D., de Herreros A.G., Varnai A., Buettner R., Bosserhoff A.K. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J. Biol. Chem. 2001, 276:24661-24666.
58. Hudson L.G., Choi C., Newkirk K.M., Parkhani J., Cooper K.L., Lu P., Kusewitt D.F. Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes. Mol. Carcinog. 2007, 46:257-268.